Refine
Has Fulltext
- yes (341)
Year of publication
Document Type
- Journal article (341) (remove)
Keywords
- ischemic stroke (26)
- Parkinson’s disease (17)
- deep brain stimulation (16)
- multiple sclerosis (15)
- neuroinflammation (15)
- Fabry disease (14)
- Parkinson's disease (14)
- stroke (13)
- Medizin (11)
- inflammation (10)
- neuropathic pain (9)
- pain (8)
- subthalamic nucleus (8)
- neurology (7)
- B cells (6)
- acute ischemic stroke (6)
- biomarker (6)
- cytokines (6)
- depression (6)
- dopamine (6)
- dystonia (6)
- fibromyalgia syndrome (6)
- mouse model (6)
- neurodegeneration (6)
- MS (5)
- antibodies (5)
- blood-brain barrier (5)
- middle cerebral artery occlusion (5)
- neuroprotection (5)
- traumatic brain injury (5)
- tremor (5)
- walking (5)
- GFAP (4)
- MRI (4)
- autoantibodies (4)
- basal ganglia (4)
- blood–brain barrier (4)
- cervical dystonia (4)
- disease (4)
- factor XII (4)
- immunohistochemistry (4)
- inflammasome (4)
- macrophages (4)
- magnetic resonance imaging (4)
- mechanical thrombectomy (4)
- movement disorders (4)
- mutation (4)
- neuropathy (4)
- platelets (4)
- skin punch biopsy (4)
- small fiber neuropathy (4)
- thrombo-inflammation (4)
- COVID-19 (3)
- EAE (3)
- Fabry-associated pain (3)
- Gehirn (3)
- HBMEC (3)
- Mice (3)
- Multiple sclerosis (3)
- NLRP3 (3)
- Neurodegeneration (3)
- Neuromyelitis optica spectrum disorders (NMOSD) (3)
- Optic neuritis (3)
- Pain (3)
- Parkinson disease (3)
- Schlaganfall (3)
- T cells (3)
- Ureaplasma parvum (3)
- animal models (3)
- anxiety (3)
- biomarkers (3)
- brain (3)
- cerebellar tDCS (3)
- cerebral ischemia (3)
- children (3)
- closed head injury (3)
- cognitive impairment (3)
- criteria (3)
- enzyme replacement therapy (3)
- essential tremor (3)
- experimental autoimmune encephalomyelitis (3)
- experimental stroke (3)
- expression (3)
- gait initiation (3)
- gene expression (3)
- genetics (3)
- heart failure (3)
- kinematics (3)
- length of stenosis (3)
- local field potentials (3)
- lymphocytes (3)
- macrophage (3)
- mesencephalic locomotor region (3)
- mice (3)
- microglia (3)
- myelin (3)
- neurofilament light chain (3)
- neuroimmunology (3)
- neutrophils (3)
- photothrombotic stroke (3)
- polyneuropathy (3)
- quality of life (3)
- regulatory T cells (3)
- tMCAO (3)
- therapy (3)
- tight junctions (3)
- transplantation (3)
- trial (3)
- Alzheimer’s disease (2)
- Autoantibodies (2)
- B7-H1 (2)
- Cerebrospinal fluid (2)
- Charcot-Marie-Tooth (2)
- DYT1 (2)
- Diagnosis (2)
- ELISPOT (2)
- Enzyme replacement therapy (2)
- Fabry genotype (2)
- Fabry phenotype (2)
- Fibromyalgia syndrome (2)
- Glatiramer acetate (2)
- Guillain-Barre-Syndrome (2)
- Inflammation (2)
- Langerhans cells (2)
- Longitudinally extensive transverse myelitis (LETM) (2)
- MCC950 (2)
- Maus (2)
- Mechanisms (2)
- Myelin oligodendrocyte glycoprotein antibodies (MOG-IgG) (2)
- NEUROWIND (2)
- NMOSD (2)
- NOAC (2)
- Neuronal ceroid lipofuscinosis (2)
- Neuropathy (2)
- Outcome survey (2)
- PET (2)
- T lymphocytes (2)
- T-lymphocytes (2)
- Tourette syndrome (2)
- Treatment (2)
- Ureaplasma urealyticum (2)
- accuracy (2)
- adaptive immune system (2)
- aging (2)
- amyotrophic-lateral-sclerosis (2)
- animal model (2)
- atrial fibrillation (2)
- autoantibody (2)
- balance (2)
- base of support (2)
- beta oscillations (2)
- binding (2)
- blood brain barrier (2)
- blood flow (2)
- blood pressure (2)
- c-Fos (2)
- caregiver burden (2)
- carotid atherosclerosis (2)
- carotid stenosis (2)
- carotid ultrasound (2)
- case report (2)
- central nervous system (2)
- cerebral autoregulation (2)
- cerebrospinal fluid (2)
- cerebrovascular disorders (2)
- chronic cerebrovascular disease (2)
- chronic kidney disease (2)
- chronic pain (2)
- colony-stimulating factor (2)
- contact-kinin system (2)
- degree of stenosis (2)
- dementia (2)
- diagnosis (2)
- diagnostic markers (2)
- differential diagnosis (2)
- dimethyl fumarate (2)
- disability (2)
- diseases of the nervous system (2)
- echocardiography (2)
- edema (2)
- electrophysiology (2)
- endoglin (2)
- endothelial cells (2)
- exercise (2)
- fibromyalgia (2)
- gait (2)
- gait analysis (2)
- gene (2)
- generalized cerebral edema (2)
- glial fate modulation (2)
- glial fibrillary acidic protein (2)
- globotriaosylceramide (2)
- glycine receptor (2)
- glycoprotein receptor Ib (2)
- guidelines (2)
- hearing loss (2)
- hypoxia (2)
- immune cells (2)
- immunomodulation (2)
- in vivo imaging (2)
- induced pluripotent stem cells (2)
- infarction (2)
- inflammatory neuropathy (2)
- ion channels (2)
- ischemic penumbra (2)
- lesions (2)
- leukocytes (2)
- locomotor adaptation (2)
- locus coeruleus (2)
- machine learning (2)
- major depression (2)
- meningitis (2)
- microRNA (2)
- mitochondria (2)
- mortality (2)
- motor learning (2)
- mouse models (2)
- multiple system atrophy (2)
- multiple-sclerosis (2)
- nerve fibers (2)
- neurofascin (2)
- neurological disorders (2)
- neurons (2)
- opioids (2)
- outcomes (2)
- passive transfer (2)
- pathogenesis (2)
- photothrombosis (2)
- physical activity (2)
- preclinical research (2)
- predictive value (2)
- protein (2)
- randomized controlled trial (2)
- rat (2)
- relapse (2)
- renal system (2)
- reversible posterior leukoencephalopathy syndrome (2)
- second hit (2)
- spinal cord (2)
- spinal cord injury (2)
- split-belt treadmill (2)
- stroke unit (2)
- synaptic vesicles (2)
- telemedicine (2)
- thrombosis (2)
- transient ischemic attack (2)
- transient middle cerebral artery occlusion (2)
- velocity (2)
- voluntary movement (2)
- von Willebrand factor (2)
- 2B (1)
- 3D fluoroscopy (1)
- 5IA-SPECT (1)
- 65-kda isoform (1)
- A-delta fibers (1)
- A53T (1)
- ADHD (1)
- ALS (1)
- ALS mimic (1)
- ALS treatment (1)
- ALSIN gene (1)
- APERIO (1)
- APERIO Hybrid (1)
- AQP4 (1)
- ASC (1)
- Adaptive cell transfer (1)
- Adult patients (1)
- Agalsidase beta (1)
- Agalsidase beta therapy (1)
- Alemtuzumab (1)
- Alpha galactosidase (1)
- Alzheimer disease (1)
- Alzheimer’s dementia (1)
- Amplitude (1)
- Amyotrophic Lateral Sclerosis (ALS) (1)
- Amyotrophic Lateral Sclerosis Assessment Questionnaire 5 (ALSAQ-5) (1)
- Anderson-Fabry Disease (1)
- Animal models (1)
- Antibody index (1)
- Antiparanodal Autoantibodies (1)
- Anxiety (1)
- Apoptosis (1)
- Aquaporin-4 antibodies (AQP4-Ig, NMO-IgG)G (1)
- Aquaporin-4 antibodies (AQP4-IgG) (1)
- Aquaporin-4 antibodies (AQP4-IgG, NMO-IgG) (1)
- Arterial Diameters (1)
- Arterial water (1)
- Ataxia (1)
- Atrial fibrillation (1)
- Axon degeneration (1)
- Axonal degeneration (1)
- Azathioprine (1)
- Aδ- and C-fibers (1)
- B-lymphocytes (1)
- BB/OKL rats (1)
- BDNF (1)
- Barkhof criteria (1)
- Beta-glucocerebrosidase (1)
- Biomarker (1)
- Braak (1)
- Brain (1)
- Brain atrophy (1)
- Brain edema (1)
- Brain ischemia (1)
- Brainstem encephalitis (1)
- C-reactive protein (1)
- C.376A>G (p.S126G) (1)
- C1-inhibitor (1)
- C57BL/6 mice (1)
- CCI (1)
- CCS (1)
- CD105 (1)
- CD133 (1)
- CD19 (1)
- CD52 (1)
- CIDP (1)
- CLN3 (1)
- CMV (1)
- CNS (1)
- CNS Myelination (1)
- CNS disease (1)
- CNS imaging (1)
- CNS integrity (1)
- COMPLEX 1 (1)
- COU254 (1)
- CRPS (1)
- CSF (1)
- CSVD (1)
- CXCL4 (1)
- CXCL5 (1)
- CXCL7 (1)
- CXCL8 (1)
- CXCR2 (1)
- Ca2+ homeostasis (1)
- Ca2+ ion analysis (1)
- Ca2+ leak (1)
- Ca2+ oscillation (1)
- Capsaicin receptor (1)
- Caspase (1)
- Cell Index (1)
- Cell therapy (1)
- Cell-based assays (1)
- Cerebellitis (1)
- Cerebral blood flow (1)
- Cerebral small vessel disease (1)
- Cerebral vasospasm (1)
- Cerebral-ischemia (1)
- Charcot-Marie-Tooth disease (1)
- Charcot–Marie–Tooth disease (1)
- Charcot–Marie–Tooth disease type 1A (1)
- CholinomiRs (1)
- Chronic heart failure (1)
- Chronic neuropathic pain (1)
- Cisterna magna (1)
- Clinical manifestations (1)
- Clinically silent stroke (1)
- Coefficient (1)
- Cognitive behavior (1)
- Cognitive decline (1)
- Cold (1)
- Computertomographie (1)
- Corneal confocal microscopy (1)
- Crespi effect (1)
- Cytokines (1)
- D313Y genotype (1)
- DARPA (1)
- DBS biomarkers (1)
- DBS programming (1)
- DOPA-responsive-dystonia (1)
- DRD1 (1)
- Deflazacort (1)
- Delphi procedure (1)
- Demyelinating peripheral neuropathy (1)
- Devic’s syndrome (1)
- Diabetes mellitus (1)
- Diabetic polyneuropathy (1)
- Diplopia Internuclear ophthalmoplegia (INO) (1)
- Disease (1)
- Donor lymphocytes (1)
- Dose reduction (1)
- Double hemorrhage model (1)
- Duchenne dystrphy (1)
- Durchblutung (1)
- Dystonia (1)
- EEG data (1)
- ER Ca2+ imaging (1)
- ER Ca2+ store (1)
- ERK1/2 (1)
- Edema (1)
- El Escorial (1)
- Electrophysiology (1)
- English version (1)
- Epilepsy (1)
- EuroQol Five Dimension Five Level Scale (EQ-5D-5L) (1)
- Evoked potentials (1)
- Experimental stroke (1)
- Expression (1)
- F-18-FDG PET (1)
- FOSMN (1)
- FP-CIT SPECT (1)
- FTY720 (1)
- FTY720-P (1)
- FXII (1)
- FXIIa inhibitor rHA-Infestin (1)
- Fabry (1)
- Fabry cardiomyopathy (1)
- Fabry nephropathy (1)
- Facial nerve palsy (1)
- Factor messenger-RNA (1)
- Fc-receptor (1)
- Fibromyalgia (1)
- Fibromyalgie (1)
- Frabin/Fgd4 (1)
- GABAergic neurons (1)
- GCH1 (1)
- GFAP-astrocytopathies (1)
- GPCR (1)
- GRAID (1)
- Gene-expression (1)
- Gland (1)
- Glial fibrillary acidic protein (1)
- Glioblastoma (1)
- Glioma stem cells (1)
- Glutamic-acid decarboxylase anxiety (1)
- Guillain-Barré syndrome (1)
- Guillain-Barré-Syndrom (1)
- HMGB1 (1)
- Head-injury (1)
- Hearing loss (1)
- Heat Hyperalgesia (1)
- Hemodynamic depression (1)
- Hyperalgesia (1)
- IBA-1 (1)
- IENFD (1)
- IL-15 (1)
- IL-22 binding protein isoform (1)
- IL-4 (1)
- IL22RA2 (1)
- IPND criteria (1)
- IVIg (1)
- Identification (1)
- IgG (1)
- IgG4 (1)
- Immune system (1)
- Infections (1)
- Innervation (1)
- Insulin (1)
- IntelliCage (1)
- Interferon beta (1)
- Interleukin-18 (1)
- Interleukin-6 (1)
- Interleukin-6-Deficient mice (1)
- International consensus diagnostic criteria for neuromyelitis optica spectrum disorders (1)
- Intractable nausea and vomiting (1)
- Intravascular coagulation (1)
- Ischemia (1)
- Ischemic stroke (1)
- JCV (1)
- K+ channel (1)
- K2P channels (1)
- KCNK5 (1)
- K\(_{2P}\)5.1 (1)
- Kaliumkanal (1)
- L-DOPA (1)
- LI-rTMS (1)
- LIMP-2 (1)
- LSVT-big therapy (1)
- LTD (1)
- Leukemia Inhibitory Factor (1)
- Lewy-like pathology (1)
- Limb girdle muscular dystrophy (LGMD) (1)
- Long COVID (1)
- Longitudinally extensive transverse myelitis (1)
- Lysosomal storage disease (1)
- MDL-28170 (1)
- MIBG scintigraphy (1)
- MIC ligands (1)
- MMP9 (1)
- MOC fibers (1)
- MOG-IgG (1)
- MRI criteria (1)
- MSSS (1)
- Macrophage (1)
- Macrophages (1)
- Magnetic resonance imaging (1)
- Magnetic-resonance (1)
- McDonald criteria (1)
- Mediated Inflammatory Hyperalgesia (1)
- Meige syndrome (1)
- Memory dysfunction (1)
- Meningitis (1)
- Merkel cell density (1)
- Mesenchymal stem/stromal cells (1)
- Methotrexate (1)
- Microglia (1)
- Migräne (1)
- Miyoshi myopathy (1)
- Model (1)
- Molecular-weight heparin (1)
- Monopolar depression (1)
- Motor cortex (1)
- Motor nerve biopsy (1)
- Motor plasticity (1)
- Mucopolysaccharidosis IIIa (1)
- Multiple Sklerose (1)
- Mycobacterium caprae (1)
- Mycobacterium tuberculosis complex (1)
- Myelin oligodendrocyte glycoprotein (MOG) antibodies (1)
- Myelitis (1)
- Myeloma (1)
- NADPH oxidase inhibitors (1)
- NAP-2 (1)
- NETs (1)
- NF-\(\kappa\)B (1)
- NF-κB (1)
- NKG2D (1)
- NKG2D ligands (1)
- NMO-IGG (1)
- NMR-Tomographie (1)
- NPC1 gene (1)
- NPC2 gene (1)
- NPSI (1)
- Natalizumab (1)
- Necrosis-factor-Alpha (1)
- Nerve growth-factorcopy (1)
- Nestin (1)
- Neuralgie (1)
- Neurogenic inflammation (1)
- Neuroinflammation (1)
- Neuromyelitis optica (NMO) (1)
- Neuromyelitis optica antibodies (NMO-IgG) (1)
- Neurotrophic factors (1)
- Neutrophil (1)
- NfL (1)
- Niemann–Pick disease type C (1)
- Nodo-parandopathy (1)
- OCB (1)
- Ofatumumab (1)
- Oligoclonal bands (1)
- Oncostatin-M-Receptor (1)
- Opioid receptor (1)
- Optical coherence tomography (1)
- Orai2 (1)
- Oral anticoagulation (1)
- Osteopontin (1)
- Outcome (1)
- PD-L1 (1)
- PF4 (1)
- PI3K isoforms (1)
- PML (1)
- PPAR-gamme (1)
- Pain questionnaire (1)
- Pain-related evoked potentials (1)
- Paradoxical heat sensation (1)
- Parkinson (1)
- Parkinsons disease (1)
- Parkionson's disease (1)
- Perfusion (1)
- Peripheral Inflammation (1)
- Peripheral nervous system (1)
- Pharmacological management (1)
- Plasma extravasation (1)
- Pleckstrin homology containing family member 5 (Plekhg5) (1)
- Pointing error (1)
- Pregnancy (1)
- Prodigy (1)
- Progressive supranuclear palsy (1)
- Proprioception (1)
- Quality of life (1)
- R-715 (1)
- RECK (1)
- RKIP (1)
- RNA extraction (1)
- Randomized controlled trial (1)
- Randomized controlled-trial (1)
- Rat (1)
- Rat Sensory Neurons (1)
- Rats (1)
- Receptors (1)
- Regenerative medicine (1)
- Respiratory insufficiency (1)
- Retinal degeneration (1)
- Rheumatoid-Arthritis (1)
- Rho-GTPase Cdc42 (1)
- Rhombencephalitis (1)
- Richardson-Olszewski-Syndrome (1)
- Rituximab (1)
- Rochester diabetic neuropathy (1)
- SARS-CoV (1)
- SB332235 (1)
- SERCA (1)
- SGLT2 inhibitors (1)
- SHRSP (1)
- SNI (1)
- SOD1 mutations (1)
- SPG4 (1)
- SREBP (1)
- STAIR (1)
- STEMI (1)
- Sars-CoV-2 (1)
- Schlaganfall-Netzwerk (1)
- Schwann cell (1)
- Schwann cell dedifferentiation (1)
- Schwann cell differentiation (1)
- Schwann-cells (1)
- Screening questionnaire (1)
- Secondary stroke prevention (1)
- Sensitivity (1)
- Serotonin (1)
- Silver-syndrome (1)
- Sjorgens-syndrome (1)
- Skelettmuskel (1)
- Skin biopsy (1)
- Small fiber dysfunction (1)
- Small fiber neuropathy (1)
- Small-fiber neuropathy (1)
- Sonic hedgehog (1)
- Sphingosine 1-Phosphate (1)
- Stim (1)
- Stimuli (1)
- Stroke (1)
- Stroke unit (1)
- Stroke-Unit (1)
- Subarachnoid (1)
- Subarachnoid hemorrhage (1)
- Survey (1)
- System involvement (1)
- T cell activation (1)
- T-PA (1)
- T-cells (1)
- TASK2 (1)
- TBI (1)
- TDMT (1)
- TIMP-1 (1)
- TIND (1)
- TLO (1)
- TMS (1)
- TNF-α (1)
- TNFα (1)
- TOR1A (1)
- TRP Channels (1)
- TSPO (1)
- Tdp-43 (1)
- Telemedizin (1)
- Therapy (1)
- Thermal Hyperalgesia (1)
- Thrombus (1)
- Thrombus formation (1)
- Training (1)
- Transverse Myelitis (1)
- Transverse myelitis (1)
- TrkB (1)
- Tryptophan hydroxylase-2 (Tph2) (1)
- Tuberkulose (1)
- Type 1 diabetes (1)
- Umfragestudie (1)
- Ureaplasma species (1)
- VCAM-1 (1)
- Vaccination (1)
- Vasodilatator-stimuliertes Phosphoprotein (1)
- Vasodilator-Stimulated Phosphoprotein (1)
- Von-Willebrand-factor (1)
- Western blot (1)
- Wingerchuk criteria 2006 and 2015 (1)
- X-chromosomal inactivation (1)
- XAV-939 (1)
- Zonula Occludens-1 (1)
- [18F]FDG positron emission tomography (1)
- acid sphingomyelinase (1)
- activation (1)
- acute lymphoblastic leukaemia (1)
- acute management of stroke (1)
- acute neurology (1)
- acute stroke imaging (1)
- acute stroke management (1)
- acute stroke outcome (1)
- adhesion molecules (1)
- adrenal medulla (1)
- adsorption (1)
- adult-onset (1)
- advanced therapy medicinal products (1)
- afferents (1)
- age (1)
- aggression (1)
- albumin (1)
- algorithm (1)
- alias pilot trial (1)
- allodynia (1)
- alpha-7 nicotinic acetylcholine receptor (1)
- alpha-galactosidase A (1)
- alpha‐synuclein (1)
- alpha‐synuclein propagation (1)
- alpha‐synuclein seeding (1)
- amygdala (1)
- amyloidosis (1)
- amyotrophic lateral sclerosis (1)
- amyotrophic lateral sclerosis (ALS) (1)
- analgesia (1)
- analgesic medication (1)
- aneurysm surgery (1)
- angiography (1)
- animal behavior (1)
- ankles (1)
- antagomir (1)
- anthropometric measurement (1)
- anthropometric measurements (1)
- anti-aquaporin-4 antibody (1)
- anti-contactin-1 (1)
- anticoagulants (1)
- anticoagulation (1)
- antidepressants (1)
- antigen-presenting cells (1)
- apoE (1)
- apoe (1)
- apomorphine (1)
- aquaporin 4 (1)
- aquaporin-4 autoantibodies (1)
- areas (1)
- arm (1)
- artery occlusion (1)
- assistive devices (1)
- association (1)
- association studies in genetics (1)
- astrocyte (1)
- astrocytes (1)
- astrogliosis (1)
- atherosclerosis (1)
- atrophy Kennedys-disease (1)
- attention deficit/hyperactivity disorder (ADHD) (1)
- attenuation of disease (1)
- atypical chemokine receptor 3 (1)
- autoantibody (aAb) (1)
- autoimmune (1)
- autoimmune neuroinflammation (1)
- autoimmune nodopathy (1)
- autophagy (1)
- autoradiography (1)
- axonal degeneration (1)
- axonal integrity (1)
- axonal transcriptome (1)
- axonal transport (1)
- axonopathic changes (1)
- back pain (1)
- barrier (1)
- barrier integrity (1)
- basal forebrain cholinergic neurons (1)
- behavioral disorders (1)
- beta oscillation (1)
- beta power (1)
- bilateral internal carotid artery stenosis (1)
- bilateral motor network (1)
- binding analysis (1)
- biological locomotion (1)
- biopsies (1)
- biopsy (1)
- blood (1)
- blood CSF barrier (1)
- blood coagulability (1)
- blood coagulation (1)
- blood nerve barrier (1)
- blood sedimentation (1)
- bone-marrow (1)
- botulinum neurotoxin (1)
- botulinum toxin (1)
- bradykinesia (1)
- bradykinin (1)
- brain dynamics (1)
- brain edema (1)
- brain endothelium (1)
- brain metabolic alterations (1)
- brain networks (1)
- brain state (1)
- brain stem (1)
- burning pain (1)
- calpain (1)
- capsaicin (1)
- cardiac imaging (1)
- cardiac magnetic resonance imaging (1)
- cardiovascular disease (1)
- care (1)
- care tempis (1)
- caregiver (1)
- caudate nucleus (1)
- celiac disease (1)
- cell adhesion (1)
- cell binding assay (1)
- cellular therapy (1)
- cerebellar vermis hypoplasia (1)
- cerebellum (1)
- cerebral arteries (1)
- cerebral blood flow (1)
- cerebral inflammation (1)
- cerebral microbleeds (1)
- cerebral small vessel disease (1)
- cerebrospinal fluid culture (1)
- cerebrospinal-fluid (1)
- cerebrovascular diseases (1)
- chemokines (1)
- chitinase-3-like protein 1 (1)
- choline acetyltransferase (1)
- cholinergic activity (1)
- cholinergic system (1)
- chronic constriction nerve injury (1)
- chronic constriction nerve injury (CCI) (1)
- chronic heart failure (1)
- chronic stimulation (1)
- chronic stress (1)
- classification (1)
- claudin-1 (1)
- clinical approach (1)
- clinical diagnosis (1)
- clinical neurology (1)
- clinical outcome (1)
- clinical phenotype (1)
- clip control (1)
- closed-loop (1)
- cluster analysis (1)
- coagulation (1)
- coagulation factor XIIa (1)
- cochlea (1)
- cognitive (1)
- cognitive decline (1)
- cognitive function (1)
- coherence (1)
- coherence analysis (1)
- collagens (1)
- collateral circulation (1)
- colony stimulating factor 1 (1)
- compensatory strategies (1)
- complement (1)
- complement deposition (1)
- complex regional pain syndrome (1)
- comprehension (1)
- computed tomography (1)
- computer vision (1)
- consolidation (1)
- contact activation system (1)
- contactin (1)
- continuous theta burst stimulation (cTBS) (1)
- contrast (1)
- contrast-enhanced MRI (1)
- conversion (1)
- coordination (1)
- coping (1)
- corneal confocal microscopy (1)
- cortical activation (1)
- cortical excitability (1)
- cortical oscillatory activity (1)
- cortical pathology (1)
- cortical silent period (1)
- cortico-striatal synapse (1)
- crossover trial (1)
- cue (1)
- cutaneous innervation (1)
- cutaneous patch (1)
- cutting edge (1)
- dSPN (1)
- damage cool aid (1)
- darbepoetin alpha (1)
- data filtering (1)
- decreasing autonomy (1)
- deep brain stimulation (DBS) (1)
- deep brain-stimulation (1)
- degeneration (1)
- delayed cerebral infarction (1)
- delays progression (1)
- demography (1)
- demyelinating disease (1)
- demyelinating polyradiculoneuropathy (1)
- demyelination (1)
- dendric cells (1)
- dermal B cells (1)
- design (1)
- developmental signaling (1)
- diabetes mellitus (1)
- diabetic neuropathy (1)
- diagnosis in Fabry disease (1)
- diagnostic delay (1)
- diagnostic medicine (1)
- diagnostics (1)
- diffuse (1)
- digital medicine (1)
- direct pathway (1)
- directional deep brain stimulation (1)
- disease model (1)
- disease progression (1)
- disease severity (1)
- disease-modifying therapy (1)
- disorder (1)
- domain potassium channels (1)
- dopamine acetylcholine (1)
- dopamine transporter (DAT) (1)
- dopaminergic cells (1)
- drug (1)
- duodenal levodopa infusion (1)
- dysferlinopathy (1)
- edoxaban (1)
- effects (1)
- efficacy (1)
- ejection fraction (1)
- electromyography (1)
- element (1)
- embolic stroke (1)
- emulsions (1)
- encephalitis (1)
- endothelin-1 (1)
- endotheliopathy (1)
- enteropathy (1)
- enzyme assays (1)
- enzyme-linked immunoassays (1)
- epidermis (1)
- event-related desynchronization (1)
- exome sequencing (1)
- experimental (1)
- experimental autoimmune neuritis (1)
- experimental design (1)
- expert opinion (1)
- extensiv transverse myelitis (1)
- extracellular domain (1)
- eye movement disorders (1)
- facial pain (1)
- factor XI (1)
- familial amyloidotic polyneuropathy (1)
- family caregiver (1)
- fatigue (1)
- fear (1)
- fear memory (1)
- feasibility (1)
- female Fabry patients (1)
- females (1)
- fibers (1)
- fibroblast (1)
- finger-tapping task (1)
- fingolimod (1)
- flotillin-1 lipid rafts (1)
- fluorine (1)
- focal (1)
- focal brain lesion (1)
- focal cerebral ischemia (1)
- focal cerebral-ischemia (1)
- fosfomycin (1)
- free radical scavenger (1)
- freezing of gait (1)
- freezing of gait (FOG) (1)
- fullerenes (1)
- functional MRI (1)
- functional neuroanatomy (1)
- functional status (1)
- fungal infection (1)
- future directions (1)
- gadofluorine (1)
- gadolinium-DTPA (1)
- gait modulation (1)
- gait-phase prediction (1)
- galactomannan (1)
- gender (1)
- gene mutations (1)
- gene variant (1)
- gene-by-environment interaction (1)
- gene-environment interaction (1)
- generalized cerebellar atrophy (1)
- genome-wide association study (1)
- genotype-phenotype correlation (1)
- genotype/phenotype correlation (1)
- gephyrin (1)
- giant cell arteritis (1)
- glial damage (1)
- glioblastoma multiforme (1)
- globus pallidus (1)
- globus pallidus pars interna (GPi) (1)
- glycation end products (1)
- glycine receptor (GlyR) (1)
- glycine receptor autoantibodies (1)
- glycoprotein Ib (1)
- glycoprotein VI (1)
- glycoprotein receptor Ibα (1)
- glycosylation (1)
- granzyme B (1)
- gridle muscular-dystrophy (1)
- growth (1)
- growth pattern (1)
- health behavior (1)
- health-related quality of life (1)
- health-related quality of life (HRQoL) (1)
- hemicraniectomy (1)
- hemoglobin (1)
- hemorrhagic transformation (1)
- hereditary motor and sensory neuropathy (1)
- hereditary spastic paraplegia (HSP) (1)
- hernia repair (1)
- hexanucleotide repeat (1)
- high contrast (1)
- hip (1)
- hippocampus (1)
- histology (1)
- homotypic fusion and protein sorting (1)
- hospitals (1)
- human brain endothelium (1)
- human brain microvascular endothelial cells (1)
- human cerebral endothelial cells (1)
- human muscle-cells (1)
- human neurons (1)
- humans (1)
- hyperalgesia (1)
- hypercholesterolemia (1)
- hyperekplexia (1)
- hypothermia (1)
- i.v. thrombolysis (1)
- idiopathic inflammatory myopathies (1)
- image quality (1)
- image-guided programming (1)
- imaging (1)
- immaturity (1)
- immune (1)
- immune system (1)
- immune-response (1)
- immunofluorescence (1)
- immunoglobulin-G (1)
- implants (1)
- in-vivo (1)
- incidence (1)
- increased risk (1)
- induced neural stem cells (1)
- inducible expression (1)
- inebilizumab (1)
- inertial measurement units (1)
- infantile neuronal ceroid lipofuscinosis (1)
- infarction size (1)
- infarction volume (1)
- inflammatory cascades (1)
- inflammatory demyelinating polyradiculoneuropathy (1)
- informal care (1)
- informal caregiving (1)
- informed consent (1)
- inherited metabolic disorders (1)
- inherited peripheral neuropathy (1)
- injection site reactions; (1)
- innate immune system (1)
- innervation (1)
- integrin α2 (1)
- integrins (1)
- intensity of attention (1)
- interference (1)
- interleukin-1 receptor antagonist (1)
- interleukin-8 (1)
- internal carotid artery stenosis (1)
- internal globus pallidus (1)
- internal medicine (1)
- internet-based intervention (1)
- interval timing (1)
- interview (1)
- intracranial bleeding (1)
- intracranial hemorrhage (1)
- intractable hiccup (1)
- intraepidermal nerve fiber density (1)
- intraepidermal nerve fibre density (1)
- intraoperative (1)
- intrathecal application (1)
- intravenous immunoglobulin (1)
- intravenous thrombolysis (1)
- invasive electric stimulation (1)
- ipsilateral motor evoked potential (1)
- ipsilateral motor network (1)
- iron (1)
- iron dyshomeostasis (1)
- iron oxide nanoparticles (1)
- ischemia (1)
- ischemia/reperfusion injury (1)
- ischemic cascade (1)
- just noticeable difference (JND) (1)
- kallikrein-kinin system (1)
- kallikrein–kinin system (1)
- kinesthesia (1)
- kinin receptor (1)
- kinin receptors (1)
- knees (1)
- large vessel occlusion (1)
- learning (1)
- levodopa-induced dyskinesia (1)
- linkage (1)
- liponeurocytoma (1)
- locomotion (1)
- long-term pain (1)
- longitudinally extensive transverse myelitis (1)
- lymphokine-activated killer (1)
- lyso-Gb3 (1)
- lysosomal dysfunction (1)
- lysosomal enzyme (1)
- lysosomal storage disease (1)
- lyso‐Gb3 (1)
- magnesium (1)
- management (1)
- mast cells (1)
- matrix metalloproteinases (1)
- mechanical energy (1)
- mechanisms (1)
- medial ganglionic eminence (1)
- medication therapy failure (1)
- medulloblastoma (1)
- mental health (1)
- mesenchymal stem and stromal cells (1)
- mesenchymal stem cells (1)
- metaanalysis (1)
- methylphenidate (1)
- miR-182-5p (1)
- miR-21 (1)
- miRNA (1)
- miRNA expression patterns (1)
- miRNA polymorphisms (1)
- miRNA-based analgesic (1)
- miRNA-based diagnostics (1)
- mice impact (1)
- microangiopathy (1)
- microscopy (1)
- microsphere/macrosphere (1)
- microtubules (1)
- midbrain (1)
- migraine (1)
- migraineur (1)
- mixed fiber neuropathy (1)
- mixed methods (1)
- molecular signature (1)
- monocycline (1)
- monocytes (1)
- monomethyl fumarate (1)
- motoneuron disease (1)
- motor (1)
- motor axonal neuropathy (1)
- motor control (1)
- motor cortex (1)
- motor evoked potential (MEP) (1)
- motor function (1)
- motor neuron disease (1)
- motor neuropathy (1)
- motor proteins (1)
- motor-evoked potentials (MEP) (1)
- mouse (1)
- mouse brain microvascular endothelial cell cultur (1)
- movement (1)
- movement disorder (1)
- movements (1)
- multiple sklerosis (1)
- muscle atrophy (1)
- muscle strength (1)
- musical syntax (1)
- musk myasthenia gravis (1)
- myasthenia gravis (1)
- myelin biology and repair (1)
- myelination (1)
- myocardial infarction (1)
- natural history (1)
- natural killer cells (1)
- near-infrared spectroscopy (1)
- neonatal meningitis (1)
- nerve biopsy (1)
- nerve fibres (1)
- nerve tumor (1)
- nerve-fibers (1)
- nervous system (1)
- nervous-system (1)
- neural apoptosis (1)
- neural stem cell (1)
- neural stem cells (1)
- neuralgia (1)
- neurobehavioural deficits (1)
- neuroborreliosis (1)
- neurocritical care (1)
- neurocytoma (1)
- neurofilaments (1)
- neuroleukemiosis (1)
- neurological (1)
- neurological complications (1)
- neurological examination (1)
- neuromelanin (1)
- neuronal apoptosis (1)
- neuronal differentiation (1)
- neuronal network (1)
- neuronal stem cells (1)
- neuronopathy (1)
- neurophysiology (1)
- neuroplasticity (1)
- neurorepair (1)
- neuroscience (1)
- neutrophil (1)
- nicotinamide (1)
- nicotinic receptors (1)
- nociceptive Schwann cells (1)
- nociceptor sensitization (1)
- node of ranvier (1)
- nodes of Ranvier (1)
- non-motor features (1)
- nonalcoholic steatohepatitis (1)
- noradrenalin (1)
- noradrenaline (1)
- norepinephrine (1)
- novo renal transplantation (1)
- nucleus ventralis intermedius (1)
- nystagmus (1)
- object recognition memory (1)
- obstacle avoidance (1)
- occlusion (1)
- oligodendroglia (1)
- on-site examination (1)
- online systems (1)
- ontactin 1 (1)
- opioid (1)
- optic neuritis (1)
- optical coherence tomography (1)
- outcome (1)
- outer hair cell (OHC) (1)
- oxidative stress (1)
- p.R245H (1)
- p.S298P (1)
- p38 mitogen-activated protein kinase (1)
- p57kip2 (1)
- pain pattern (1)
- pain questionnaire (1)
- pain sensation (1)
- pain-associated behavior (1)
- pain-related evoked potentials (1)
- pallidal stimulation (1)
- pandemic (1)
- paranodopathy (1)
- paraparesis (1)
- parkinson disease (1)
- parkinsons disease (1)
- pathology section (1)
- pathophysiology (1)
- pathway analysis (1)
- pathways (1)
- patient reported outcome measures (1)
- patient triage (1)
- pedunculopontine nucleus (PPN) (1)
- pegylated insulin-like growth factor 1 (1)
- peptide (1)
- periperal nerve (1)
- peripheral injury (1)
- peripheral nerve involvement (1)
- peripheral nervous system (1)
- peripheral nervous-system (1)
- peripheral neuropathy (1)
- permanent and transient middle cerebral artery occlusion (1)
- pet (1)
- ph (1)
- phosphorylated tau protein (1)
- physical therapy modalities (1)
- pilot project (1)
- placebo-controlled (1)
- plaque cross-sectional area (1)
- plasma extravasation (1)
- plasma oxysterols (1)
- plasminogen (1)
- platelet activation (1)
- platelet aggregation (1)
- point-of-care echocardiography (1)
- pointing task (1)
- polymorphism (1)
- polymorphisms inflammation (1)
- polymyositis (1)
- population-based (1)
- position estimation (1)
- post-processing (1)
- post-traumatic stress disorder (1)
- postherpetic neuralgia (1)
- postural control (1)
- posture (1)
- potassium channels (1)
- potent inducer (1)
- precision medicine (1)
- prednisone (1)
- prefrontal cortex (1)
- presynaptic inhibition (1)
- preterm birth (1)
- preventive treatment (1)
- prognosis (1)
- progression (1)
- progressive ataxia (1)
- progressive encephalitis with rigidity and myoclonus (PERM) (1)
- progressive supranuclear palsy (1)
- proinflammatory cytokine (1)
- protein and mRNA expression (1)
- proteins (1)
- proteolipid protein (1)
- proteolipid protein gene (1)
- proteomics (1)
- psychological support (1)
- psychophysics (1)
- purmorphamine (1)
- quality (1)
- quality control (1)
- quality of life (QoL) (1)
- quality-control (1)
- quantitative sensory testing (1)
- qutenza (1)
- randomized controlled double-blind study (1)
- rat brain microvascular endothelial cell culture (1)
- rat hepatocytes (1)
- rats (1)
- reach-to-grasp movement (1)
- reaction-time tasks (1)
- receptor (1)
- receptor tyrosine kinase (1)
- recombinant tissue-type plasminogen activator (1)
- recommendations (1)
- recurrence (1)
- reflex (1)
- regional heterogeneity (1)
- regulation (1)
- regulatory cells (1)
- rehabilitation (1)
- reinnervation (1)
- relapsing multiple sclerosis (1)
- relapsing-remitting multiple sclerosis (1)
- religiosity (1)
- renal function (1)
- reoxygenation (1)
- reperfusion (1)
- reperfusion injury (1)
- reproducible outcome measure (1)
- reserpinized rat model (1)
- responsivity (1)
- resting tremor (1)
- retinal ganglion cells (1)
- retinocochleocerebral (1)
- rett (1)
- rhythm perception (1)
- risk (1)
- risk factors (1)
- risk of fall (1)
- rt-PA (1)
- safety and tolerability (1)
- scale (1)
- sciatic nerve (1)
- sciatic nerves (1)
- search filter (1)
- secondary infarct growth (1)
- secretome (1)
- segmental centers of mass (1)
- sensory neurons (1)
- seronegative (1)
- serotonin (1)
- serum (1)
- sex addiction (1)
- shedding (1)
- shingles (1)
- signal peptide (1)
- single photon emission computed tomography (SPECT) (1)
- skilled forelimb movements (1)
- skin biopsy (1)
- skin diseases (1)
- skin tumors (1)
- small vessel disease (1)
- small-fiber neuropathy (1)
- socioeconomic status (1)
- software (1)
- soleus muscles (1)
- soluble endoglin (1)
- somatosensory temporal discrimination (1)
- somatosensory-evoked-potentials (1)
- sphingolipids (1)
- spinal muscular atrophy (1)
- spinal-cord (1)
- spinal-cord-injury (1)
- startle disease (1)
- stenosis (1)
- stent-retriever device (1)
- steroids (1)
- stiff-person syndrome (SPS) (1)
- stimulation (1)
- store-operated Ca2+ entry (1)
- stress (1)
- striatum (1)
- stroke care (1)
- stroke networks (1)
- stromal cells (1)
- study (1)
- subarachnoid hemorrhage (1)
- subcutaneous injection (1)
- substance-P (1)
- subthalamic nucleus (STN) (1)
- survey (1)
- swimming (1)
- switch (1)
- symptom control (1)
- symptom-specific treatment (1)
- synapse (1)
- synaptic plasticity (1)
- synaptic transmission (1)
- syndrome (1)
- system (1)
- systematic review (1)
- systems biology (1)
- systolic dysfunction (1)
- target considerations (1)
- task retention (1)
- telemedicine network (1)
- temporal discrimination threshold (1)
- teriflunomide (1)
- term follow-up (1)
- tetrahydroisoquinoline derivates (1)
- tetraparesis (1)
- thrombemboli (1)
- thromboemboli (1)
- thromboembolic clot model (1)
- thromboembolic stroke (1)
- thromboinflammation (1)
- thrombolysis (1)
- thrombus formation (1)
- tics (1)
- time (1)
- time perception (1)
- timing (1)
- tissue resident T cells (1)
- tissue-plasminogen activator (1)
- tool (1)
- topography (1)
- torsinA (1)
- transcranial direct current stimulation (1)
- transcranial magnetic simulation (TMS) (1)
- transgenic mouse model (1)
- transient middle cerebral artery (1)
- transient middle cerebral artery occlusion model (1)
- transient receptor potential vanilloid 1 (TRPV1) (1)
- translation (1)
- translational research (1)
- translational stroke research (1)
- transmission electron microscopy (1)
- treatment options (1)
- treatment-induced neuropathy in diabetes (TIND) (1)
- treatment-resistant depression (1)
- trigeminal nerve (1)
- trigeminal neuropathy (1)
- troponin (1)
- tuberculous meningitis (1)
- tumor immunity (1)
- ultrasound imaging (1)
- under-dosing (1)
- up-regulation (1)
- upper limb (1)
- validation (1)
- variants of unknown significance (1)
- vascular dementia (1)
- vascular homeostasis (1)
- vascular permeability (1)
- vasculopathy (1)
- vertebrobasilar insufficiency (1)
- vertebrobasilar stroke (1)
- vertigo (1)
- vessel patency (1)
- vestibular (1)
- videooculography (1)
- virtual reality (1)
- visual activity (1)
- visual pathways (1)
- volume regulation (1)
- weight drop (1)
- white blood cells (1)
- white matter disease (1)
- white matter hyperintensities (1)
- white matter lesions (1)
- α-Galactosidase A (1)
- α-synuclein (1)
- α-synuclein-specific T cells (1)
- α‐GalA 3D‐structure (1)
- β-APP (1)
- “bulbar-onset” ALS (bALS) (1)
- “limb-onset” ALS (lALS) (1)
Institute
- Neurologische Klinik und Poliklinik (341) (remove)
Sonstige beteiligte Institutionen
- Datenintegrationszentrum Würzburg (DIZ) (1)
- Interdisziplinäre Biomaterial- und Datenbank Würzburg (ibdw) (1)
- Interdisziplinäres Amyloidosezentrum Nordbayern (1)
- Klinische Studienzentrale (Universitätsklinikum) (1)
- Wurzburg Fabry Center for Interdisciplinary Therapy (FAZIT), Wurzburg, Germany (1)
- Würzburg Fabry Center for Interdisciplinary Therapy (FAZIT), University of Würzburg, Würzburg, Germany (1)
Background and Purpose: Reperfusion following transient global cerebral ischemia is characterized by an initial hyperemic phase, which precedes hypo perfusion. The pathogenesis of these flow derangements remains obscure. Our study investigates the dynamics of postischemic cerebral blood flow changes, with particular attention to the role of local neurons. Metho(Js: We assessed local cortical blood flow continuously by laser Doppler flowmetry to permit observation of any rapid flow changes after forebrain ischemia induced by four-vessel occlusion for 20 minutes in rats. To investigate the role of local cortical neurons in the regulation of any blood flow fluctuations, five rats received intracortical microinjections of a neurotoxin (10 p,g ibotenic acid in 1 p,1; 1.5-mm-depth parietal cortex) 24 hours before ischemia to induce selective and localized neuronal depletion in an area corresponding to the sampie volume of the laser Doppler probe (1 mm3 ). Local cerebral blood flow was measured within the injection site and at an adjacent control site. Results: Ischemia was followed by marked hyperemia (235 ±23% of control, n =7), followed by secondary hypoperfusion (45±3% of control, n=7). The transition from hyperemia to hypoperfusioo occurred not gradually but precipitously (maximal slope of flow decay: 66±6%/min; n=7). In ibotenic acid-injected rats, hyperemia was preserved at the injection site, but the sudden decline of blood flow was abolished (maximal slope of flow decay: 5±3%/min compared with 53±8%/min at the control site; n=5, p<O.OOI) and 00 significant hypoperfusion de\eloped (103±20% of control at 60 minutes). Conclusions: These data suggest that the rapid transition to cortical hypo perfusion after forebrain ischemia may be triggered locally by a neuronal mechanism but that this mechanism does not underlie the initial hyperemia.